Epidemiological study for patients with bacteremia in Toyama, Japan: multicenter prospective observational study

Epidemiological study for patients with bacteremia in Toyama, Japan: multicenter prospective observational study - Epidemiological study for patients with bacteremia in Toyama, Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054915

Enrollment

1500

Registered

2024-07-12

Start date

2024-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacteremia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Any bacteria isolated from blood culture. 2. over 18 years old.

Exclusion criteria

Exclusion criteria: (1) The patient was previously included in the same cohort of this study, during the study period.

Design outcomes

Primary

Measure	Time frame
1) Clinical failure within 30 days after the onset of bacteremia (fulfilling at least 1 of the following indicators; recurrent bacteremia or initial infection, local suppurative complication, metastatic infection, death due to any cause). 2) Source of bacteremia 3) Identified pathogens and drug resistance	—

Secondary

Measure	Time frame
1) Clinical management of patients with bacteremia during the episode -Antibiotic therapy used during the episodes (empirical and targeted) -Non antibiotic therapy/support therapy used during the episode. -Frequency of focus search and adequate control 2) Developing and validating a predictive model for mortality. 3) Quality indicators in the management of bacteremia. 4) Interventions made by antimicrobial stewardship team (AST) -Frequency and type of interventions made by AST -Impact of these interventions in the management and prognosis of episodes.	—

Measure

Time frame

1) Clinical management of patients with bacteremia during the episode -Antibiotic therapy used during the episodes (empirical and targeted) -Non antibiotic therapy/support therapy used during the episode. -Frequency of focus search and adequate control 2) Developing and validating a predictive model for mortality. 3) Quality indicators in the management of bacteremia. 4) Interventions made by antimicrobial stewardship team (AST) -Frequency and type of interventions made by AST -Impact of these interventions in the management and prognosis of episodes.

—

Countries

Japan

Contacts

Public ContactKentaro Nagaoka

University of Toyama Clinical infectious diseases

knagaoka@med.u-toyama.ac.jp+81764347245

Outcome results